Related Experiment Video
Updated: Jun 19, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III AND THE NORMAL VARIATION IN RESISTANCE TO THESE TYPES AMONG
1Bureau of Laboratories, Department of Health of the City of New York, New York.
Older rats exhibit natural immunity to pneumococcus Type II and III infections. Active immunity against these bacterial types can be induced in rats through feeding dead bacteria or cell filtrates.
Area of Science:
- Immunology
- Microbiology
- Animal Models
Background:
- Pneumococcus infections pose significant health risks.
- Understanding natural and acquired immunity is crucial for developing effective treatments.
- Rats serve as a valuable model organism for studying infectious diseases.
Purpose of the Study:
- To investigate age-related natural resistance to Streptococcus pneumoniae (pneumococcus) Types II and III in rats.
- To explore methods for inducing active immunity against pneumococcus Types II and III in rats.
Main Methods:
- Comparative survival studies of young and old rats exposed to pneumococcus Type II and III.
- Administration of heat-killed pneumococcus organisms or cell filtrates to induce active immunity.
- Assessment of acquired immunity by challenging rats with live pneumococcus.
Main Results:
- Older rats demonstrated significantly higher survival rates against pneumococcus Type II and III compared to younger rats, indicating acquired natural immunity.
- Natural immunity developed later in life for Type III and was less pronounced than for Type II.
- Feeding dead pneumococcus or its cell filtrate successfully induced active immunity in rats against Types II and III, similar to findings for Type I.
Conclusions:
- Age is a significant factor in natural resistance to pneumococcus infections in rats.
- Active immunization against pneumococcus Types II and III is achievable through oral administration of bacterial components.
- These findings contribute to understanding host-pathogen interactions and inform potential vaccine development strategies.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
08:52Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019